Search - tctmd.com

Displaying 41 - 60 of 60

Sort: Relevancy | Date

Presentation TCT 2017

Complications During and After PFO Closure, Case #3: Arrhythmias

Presenter: John F. Rhodes, Robert J. Sommer

November 01, 2017

Presentation TCT 2017

Next Generation Bio Innovation

Presenter: Andreu M Climent, Amit N. Patel

October 31, 2017

Presentation TCT 2017

Heterogeneous Tissue Is Most Important! Reduction of the Substrate for Ventricular Arrhythmias Will Have Better Impact on Cardiovascular Mortality

Presenter: Andreu M Climent, Amit N. Patel, Angel Arenal

October 31, 2017

Presentation TCT 2017

Focal Reduction of Scar to Reduce Ventricular Arrhythmias

Presenter: Andreu M Climent, Amit N. Patel, Eugenio Cingolani

October 31, 2017

Presentation TCT 2017

The Clinical Point of View: The Need for and Challenges of Regenerative Strategies to Reduce Sudden Death

Presenter: Andreu M Climent, Amit N. Patel, Gary L. Schaer

October 31, 2017

Presentation TCT 2017

Is Ventricular Arrhythmia After Ablation a Real Phenomenon?

Presenter: Srihari S. Naidu, Paul Sorajja, George S. Hanzel

October 30, 2017

Presentation TCT 2016

Beyond Hypertension: Autonomic Modulation Therapies for Arrhythmias

Presenter: Elazer R. Edelman, Krishna J. Rocha-Singh, Vivek Y. Reddy

October 30, 2016

Presentation TCT 2016

Role of LAA in Atrial Arrhythmias: Origin and Maintenance

Presenter: Karl-Heinz Kuck, DJ Lakkireddy, Freek W.A. Verheugt

October 30, 2016

Presentation TVT 2016

Conduction Disturbances and Arrhythmias After TAVR: Remaining Issues and Best Clinical Practices

Presenter: Josep Rodés-Cabau

June 17, 2016

Presentation TVT 2016

Incidence and Clinical Impact of Atrial Fibrillation in TAVR Patients

Presenter: Philippe Généreux

June 16, 2016

Presentation TVT 2016

Clinical Implications of New LBBB and New Pacemakers After TAVR

Presenter: Azeem Latib

June 16, 2016

Presentation TVT 2016

Evolving Trends in the Incidence and Importance of Conduction Disturbances After TAVR

Presenter: Tamim Nazif

June 16, 2016

Presentation TCT 2015

Stem CellBased Ablation for Ventricular Arrhythmias

Presenter: Nabil Dib, Philippe Menasché, Angel Arenal

October 15, 2015

Presentation TVT 2015

Prevention and Management of Conduction Disturbances and Arrhythmias (AF) After TAVR

Presenter: Tamim Nazif

June 05, 2015

Presentation TVT 2015

Incidence and Prognostic Impact of Conduction Disturbances and Arrhythmias (AF) After TAVR

Presenter: Josep Rodés-Cabau

June 05, 2015

Presentation TCT 2014

Renal Denervation for Atrial and Ventricular Arrhythmias: Status and Case Examples

Presenter: Michael R. Jaff, Horst Sievert, Michael J. Rinaldi, Vivek Y. Reddy

September 14, 2014

Presentation TCT 2013

Case #2: Can Renal Denervation Reduce the Frequency of Ventricular Arrhythmias in Electrical Storm?

Presenter: Luciana Armaganijan

October 30, 2013

Presentation TCT 2013

LVAD Complications State-of-the-Art: Current Status on Thrombosis, Stokes, Bleeding and Arrhythmias

Presenter: Keith Aaronson

October 28, 2013

Presentation TCT 2013

Electrophysiological Considerations for Renal Denervation: Implications for Arrhythmia Control

Presenter: Vivek Reddy

October 27, 2013

Presentation TCT 2012

Year in Review: Arrhythmias

Presenter: John Camm

October 23, 2012

Advertisement

Complications During and After PFO Closure, Case #3: Arrhythmias

Next Generation Bio Innovation

Heterogeneous Tissue Is Most Important! Reduction of the Substrate for Ventricular Arrhythmias Will Have Better Impact on Cardiovascular Mortality

Focal Reduction of Scar to Reduce Ventricular Arrhythmias

The Clinical Point of View: The Need for and Challenges of Regenerative Strategies to Reduce Sudden Death

Is Ventricular Arrhythmia After Ablation a Real Phenomenon?

Beyond Hypertension: Autonomic Modulation Therapies for Arrhythmias

Role of LAA in Atrial Arrhythmias: Origin and Maintenance

Conduction Disturbances and Arrhythmias After TAVR: Remaining Issues and Best Clinical Practices

Incidence and Clinical Impact of Atrial Fibrillation in TAVR Patients

Clinical Implications of New LBBB and New Pacemakers After TAVR

Evolving Trends in the Incidence and Importance of Conduction Disturbances After TAVR

Stem CellBased Ablation for Ventricular Arrhythmias

Prevention and Management of Conduction Disturbances and Arrhythmias (AF) After TAVR

Incidence and Prognostic Impact of Conduction Disturbances and Arrhythmias (AF) After TAVR

Renal Denervation for Atrial and Ventricular Arrhythmias: Status and Case Examples

Case #2: Can Renal Denervation Reduce the Frequency of Ventricular Arrhythmias in Electrical Storm?

LVAD Complications State-of-the-Art: Current Status on Thrombosis, Stokes, Bleeding and Arrhythmias

Electrophysiological Considerations for Renal Denervation: Implications for Arrhythmia Control

Year in Review: Arrhythmias

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content